过敏性结膜炎的过敏原免疫治疗机制及疗效的研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

山东省医药卫生科技发展计划项目(No.202007021388)


Research progress of allergen immunotherapy mechanism and efficacy of allergic conjunctivitis
Author:
Affiliation:

Fund Project:

Medical and Health Science and Technology Development Plan Project of Shandong Province(No.202007021388)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    过敏性结膜炎是过敏性眼病最常见的类型,尤其儿童、青少年发病率逐年上升。药物治疗仅能对部分过敏性结膜炎有效,且只能短期内缓解症状,而过敏原免疫治疗是一种有效的治疗方法,可以显著改善慢性过敏的症状以及疾病的发病病程。该方法在国外已经应用多年,但在我国尚未见报道。文章将对该治疗方法的有效性机制及几种免疫治疗方法的临床疗效进行综述,为其下一步在我国的临床应用提供参考。

    Abstract:

    Allergic conjunctivitis is the most common type of allergic eye disease, and the incidence in children and adolescents is increasing year by year. Drug therapy can only relieve some symptoms and only in a short period, while allergen immunotherapy is currently a therapy that can significantly improve the symptoms of chronic allergy and the course of the disease. This method has been used abroad for many years but has yet to be reported in China. The author reviews the effective mechanism and clinical efficiency of allergen immunotherapy and provides a reference for the further clinical application in China.

    参考文献
    相似文献
    引证文献
引用本文

孙学泉,林吉娇,赵雅婷,等.过敏性结膜炎的过敏原免疫治疗机制及疗效的研究进展.国际眼科杂志, 2024,24(10):1595-1599.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-03-22
  • 最后修改日期:2024-08-20
  • 录用日期:
  • 在线发布日期: 2024-09-14
  • 出版日期:
文章二维码